Blood pressure medicine recalled over high levels of cancer-causing

Date:

Blood pressure medicine recalled over high levels of cancer-causing

More than half one million bottles of blood pressure medication have been recalled over high levels of a chemical compound that may trigger cancer, the Food and Drug Administration said.

Parsippany, NJ-based Teva Pharmaceuticals USA recalled 580,844 bottles of Prazosin Hydrochloride earlier this month.

The medication is an alpha blocker taken to decrease high blood pressure.

More than half one million bottles of blood pressure medication have been recalled. Teva Pharmaceuticals

Testing revealed high levels of “N-nitroso Prazosin impurity C” in the drug, the FDA said. Teva Pharmaceuticals

Testing revealed high levels of “N-nitroso Prazosin impurity C” in the drug, the FDA said last week.

The chemical’s focus was so high that it surpassed the FDA’s security limits for its potential to trigger cancer.

Different variations of the drug – including 1 mg, 2 mg and 5 mg doses – have been included in the recall affecting bottles with anyplace from 100 to 1,000 capsules.

The FDA not too long ago categorised the recall as Class II, which is the second-highest of three threat levels.

A Class II label signifies that use of the medication “may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote,” according to the company.

As of Thursday morning, the drugmaker apparently had not offered directions on whether or not customers ought to toss or flip in bottles of the recalled product.

Teva Pharmaceuticals USA didn’t instantly reply to The Post’s request for remark.



Navigate the fast-paced world of enterprise with us. At TheGossipBlogger.com/enterprise, we offer well timed and insightful coverage on all the pieces from market traits and startup success tales to monetary news, entrepreneurship suggestions, and global financial shifts.

Whether you are an aspiring entrepreneur, a small enterprise proprietor, or a seasoned govt, our content is designed to tell, empower, and inspire your next transfer in the enterprise world.

Our editorial team dives deep into real-world methods, company profiles, and professional analysis to convey you articles that matter. We simplify advanced enterprise developments and highlight the innovations, challenges, and alternatives shaping industries today.

Make positive to bookmark our Business part and go to often — in a world that never stops shifting, staying informed is your greatest benefit.

Share post:

img

Popular

Read more articles
Related

How Iranian bank collapse fueled economic unrest, protests: report

How Iranian bank collapse fueled economic unrest, protests: report An...

Investors call crypto coin backed by Eric Adams a...

Investors call crypto coin backed by Eric Adams a...

Elon Musk makes Tesla’s full self-driving package only available...

Elon Musk makes Tesla's full self-driving package only available...

Citi profits hit by Russia charge amid strong dealmaking...

Citi profits hit by Russia charge amid strong dealmaking...

BofA CEO Brian Moynihan ‘bullish’ on US economy as...

BofA CEO Brian Moynihan 'bullish' on US economy as...

Exclusive | Inside the peptide gray market where people...

Exclusive | Inside the peptide gray market where people...

Wells Fargo posts higher profits after Fed scraps asset...

Wells Fargo posts higher profits after Fed scraps asset...

Saks Fifth Avenue files for bankruptcy after Neiman Marcus...

Saks Fifth Avenue files for bankruptcy after Neiman Marcus...

Inflation rises 2.7% as Trump ramps up pressure on...

Inflation rises 2.7% as Trump ramps up pressure on...

Carnegie Hall settles trademark lawsuit against Carnegie Diner

Carnegie Hall settles trademark lawsuit against Carnegie Diner Carnegie Hall...